Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
The International Journal of Biochemistry & Cell Biology|May 13, 2010
Metabolism and cell shape in cancer: a fractal analysisFabrizio D'Anselmi, Mariacristina Valerio, Alessandra Cucina, et al.
Anticancer Research|July 31, 2013
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II studyFable Zustovich, Lorenza Landi, Giuseppe Lombardi, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETsPinuccia Faviana, Laura Boldrini, Carlo Gentile, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on SurvivalElisabetta Gambale, Valeria Emma Palmieri, Virginia Rossi, et al.
EJNMMI Research|November 27, 2021
[<sup>18</sup>F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancerMartina Sollini, Francesco Bartoli, Lara Cavinato, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2020
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abirateroneStefania Crucitta, Marzia Del Re, Federico Paolieri, et al.
Oncology Research and Treatment|May 11, 2016
Long-Term PSA Control with Repeated Stereotactic Body Radiotherapy in a Patient with Oligometastatic Castration-Resistant Prostate CancerFrancesco Pasqualetti, Paola Cocuzza, Gabriele Coraggio, et al.
American Journal of Hematology|April 11, 2012
The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study)Walter Ageno, Benilde Cosmi, Angelo Ghirarduzzi, et al.
Clinical Genitourinary Cancer|January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or PazopanibMartina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatmentMarzia Del Re, Stefania Crucitta, Giuliana Restante, et al.
Pageof 15